Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion

H. Cody Meissner; Robert C. Welliver; Stephan A. Chartrand; Barbara J. Law; Leonard E. Weisman; Henry L. Dorkin; William J. Rodriguez

doi:10.1097/00006454-199903000-00004

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion

H. Cody Meissner
, Robert C. Welliver
, Stephan A. Chartrand
, Barbara J. Law
, Leonard E. Weisman
, Henry L. Dorkin
, William J. Rodriguez

Pediatrics

Tufts University
Tufts-New England Medical Center
Creighton University
University of Manitoba
Baylor College of Medicine
Children's National Medical Center

Research output: Contribution to journal › Review article › peer-review

114 Scopus citations

Original language	English
Pages (from-to)	223-231
Number of pages	9
Journal	Pediatric Infectious Disease Journal
Volume	18
Issue number	3
DOIs	https://doi.org/10.1097/00006454-199903000-00004
State	Published - Mar 1999

Keywords

Bronchiolitis
Chronic lung disease
Monoclonal antibody
Palivizumab
Prematurity
Respiratory syncytial virus

Access to Document

10.1097/00006454-199903000-00004

Cite this

Meissner, H. C., Welliver, R. C., Chartrand, S. A., Law, B. J., Weisman, L. E., Dorkin, H. L., & Rodriguez, W. J. (1999). Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion. Pediatric Infectious Disease Journal, 18(3), 223-231. https://doi.org/10.1097/00006454-199903000-00004

@article{abd5822b783c4d66b669b688d37dd4dc,

title = "Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion",

keywords = "Bronchiolitis, Chronic lung disease, Monoclonal antibody, Palivizumab, Prematurity, Respiratory syncytial virus",

author = "Meissner, \{H. Cody\} and Welliver, \{Robert C.\} and Chartrand, \{Stephan A.\} and Law, \{Barbara J.\} and Weisman, \{Leonard E.\} and Dorkin, \{Henry L.\} and Rodriguez, \{William J.\}",

year = "1999",

month = mar,

doi = "10.1097/00006454-199903000-00004",

language = "English",

volume = "18",

pages = "223--231",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Meissner, HC, Welliver, RC, Chartrand, SA, Law, BJ, Weisman, LE, Dorkin, HL & Rodriguez, WJ 1999, 'Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion', Pediatric Infectious Disease Journal, vol. 18, no. 3, pp. 223-231. https://doi.org/10.1097/00006454-199903000-00004

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion. / Meissner, H. Cody; Welliver, Robert C.; Chartrand, Stephan A. et al.
In: Pediatric Infectious Disease Journal, Vol. 18, No. 3, 03.1999, p. 223-231.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants

T2 - A consensus opinion

AU - Meissner, H. Cody

AU - Welliver, Robert C.

AU - Chartrand, Stephan A.

AU - Law, Barbara J.

AU - Weisman, Leonard E.

AU - Dorkin, Henry L.

AU - Rodriguez, William J.

PY - 1999/3

Y1 - 1999/3

KW - Bronchiolitis

KW - Chronic lung disease

KW - Monoclonal antibody

KW - Palivizumab

KW - Prematurity

KW - Respiratory syncytial virus

UR - https://www.scopus.com/pages/publications/0032988719

U2 - 10.1097/00006454-199903000-00004

DO - 10.1097/00006454-199903000-00004

M3 - Review article

C2 - 10093942

AN - SCOPUS:0032988719

SN - 0891-3668

VL - 18

SP - 223

EP - 231

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 3

ER -

Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL et al. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion. Pediatric Infectious Disease Journal. 1999 Mar;18(3):223-231. doi: 10.1097/00006454-199903000-00004

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion

Keywords

Access to Document

Other files and links

Fingerprint

Cite this